Deliberations were held on new avenues in anti-narcotics and manufacturing of medication to treat drug dependence for the US and other markets in the backdrop of firms globally pursuing the China-Plus-One strategy
<br />
NEP | 14/11/2022 | By Sudeep Soparkar | 563
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy